Raman Prakash 4

What Happened

• Raman Prakash, a director of Olema Pharmaceuticals (NASDAQ: OLMA), received derivative awards on April 28, 2026: options covering 2,911 shares and 24,150 shares (27,061 shares total). The Form 4 records the acquisition price as $0.00 (award/grant entry); these are option grants, not stock sales or exercises.

Key Details

• Transaction date: April 28, 2026; Form 4 filed April 29, 2026 (timely).
• Transaction type/code: A — Grant/Award (derivative instrument: options).
• Amounts: 2,911 and 24,150 optioned shares (27,061 shares total). Reported price on the form: $0.00.
• Vesting (from filing footnotes):
  • Footnote 1: the 2,911-share option vests in full on June 11, 2026, subject to continuous service.
  • Footnote 2: the 24,150-share option vests in 36 equal monthly installments beginning April 28, 2026, subject to continuous service.
• Shares owned after transaction: Not specified in the provided filing.

Context

• These were option grants (award of a derivative right to acquire shares) — not exercises or sales. The awards will convert into owned shares only as they vest and (if applicable) are exercised according to plan terms.
• Equity grants to directors are common compensation; they do not represent an immediate open-market purchase or sale and should not be read as an immediate buy/sell signal.